These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 26131055)
1. Roles of sigma-1 receptors in Alzheimer's disease. Jin JL; Fang M; Zhao YX; Liu XY Int J Clin Exp Med; 2015; 8(4):4808-20. PubMed ID: 26131055 [TBL] [Abstract][Full Text] [Related]
2. Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists. Maurice T Drug News Perspect; 2002 Dec; 15(10):617-625. PubMed ID: 12677246 [TBL] [Abstract][Full Text] [Related]
3. The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer's. Prasanth MI; Malar DS; Tencomnao T; Brimson JM Expert Opin Ther Targets; 2021 May; 25(5):401-414. PubMed ID: 34110944 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow. Volloch V; Olsen B; Rits S Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536 [TBL] [Abstract][Full Text] [Related]
5. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope. Sonkusare SK; Kaul CL; Ramarao P Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530 [TBL] [Abstract][Full Text] [Related]
6. Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Yin J; Sha S; Chen T; Wang C; Hong J; Jie P; Zhou R; Li L; Sokabe M; Chen L Neuropharmacology; 2015 Feb; 89():215-24. PubMed ID: 25286118 [TBL] [Abstract][Full Text] [Related]
7. Sigma-2 Receptor as a Potential Drug Target. Chen AF; Ma WH; Xie XY; Huang YS Curr Med Chem; 2021; 28(21):4172-4189. PubMed ID: 32881653 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies. Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446 [TBL] [Abstract][Full Text] [Related]
9. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
10. Role of σ Maurice T; Goguadze N Adv Exp Med Biol; 2017; 964():213-233. PubMed ID: 28315274 [TBL] [Abstract][Full Text] [Related]
11. Contribution of Lysosome and Sigma Receptors to Neuroprotective Effects of Memantine Against Beta-Amyloid in the SH-SY5Y Cells. Keshavarz M; Farrokhi MR; Amirinezhad Fard E; Mehdipour M Adv Pharm Bull; 2020 Jul; 10(3):452-457. PubMed ID: 32665905 [No Abstract] [Full Text] [Related]
12. NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease. Lin CH; Huang YJ; Lin CJ; Lane HY; Tsai GE Curr Pharm Des; 2014; 20(32):5169-79. PubMed ID: 24410566 [TBL] [Abstract][Full Text] [Related]
13. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. Lipton SA J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416 [TBL] [Abstract][Full Text] [Related]